注射吸毒相关就诊中HIV检测的错失机会:辛辛那提/北肯塔基2017-2018年HIV暴发队列分析
该研究纳入2017年1月至2018年9月辛辛那提/北肯塔基5县新诊断HIV且诊断前12个月至少1次就诊的注射吸毒者,从电子健康记录提取检测与就诊数据。109例中75例(68.8%)有注射吸毒相关就诊,169次此类就诊中86次(50.9%)为HIV检测错失机会,多发生于急诊科。结论提示应加强急诊等场景对注射吸毒者的HIV筛查以促进早期诊断和暴发应对。
要点
- 注射吸毒者诊断前常有多次相关就诊,但半数此类就诊未做HIV检测
- 注射吸毒相关就诊近七成发生在急诊科,是筛查重点场景
- 住院就诊及有急诊HIV检测经费的医疗系统检测率更高
核心结论
- 注射吸毒者在HIV诊断前有频繁的注射吸毒相关就诊,其中约半数未进行HIV检测,多为急诊科就诊。
- 加强上述场景对注射吸毒者的HIV筛查可促进早期诊断并改善暴发应对。
研究设计与样本
- 回顾性队列分析,纳入2017年1月至2018年9月5个辛辛那提/北肯塔基县新诊断HIV、且诊断前12个月在2个地区医疗系统至少1次就诊的注射吸毒者。
- HIV检测与就诊数据从电子健康记录中提取;错失机会定义为因注射吸毒相关情况进行就诊时未做HIV检测且此前12个月未检测。
主要发现
- 109例有至少1次就诊的注射吸毒者中,75例(68.8%)在HIV诊断前12个月有至少1次注射吸毒相关就诊。
- 这75例共有169次注射吸毒相关就诊,其中86次(50.9%)为HIV检测错失机会,涉及46例(42.2%)。
- 注射吸毒相关就诊多数发生在急诊科(118/169;69.8%)。
- 多变量广义估计方程显示,住院就诊比急诊就诊更可能进行HIV检测(校正相对危险度[RR] 2.72;95%置信区间[CI] 1.70-4.33)。
- 在获得急诊HIV检测经费的医疗系统就诊更可能检测(校正RR 1.76;95%CI 1.10-2.82)。
临床怎么用
- 对因注射吸毒相关情况就诊者,尤其在急诊科,应主动提供HIV检测以减少错失机会。
- 可借鉴获得急诊HIV检测经费的医疗系统经验,推动急诊常规HIV筛查。
- 将注射吸毒相关就诊视为HIV筛查触发点,有助于暴发期间更早发现病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Persons who inject drugs (PWID) have frequent healthcare encounters related to their injection drug use (IDU) but are often not tested for human immunodeficiency virus (HIV). We sought to quantify missed opportunities for HIV testing during an HIV outbreak among PWID. METHODS: PWID with HIV diagnosed in 5 Cincinnati/Northern Kentucky counties during January 2017-September 2018 who had ≥1 encounter 12 months prior to HIV diagnosis in 1 of 2 Cincinnati/Northern Kentucky area healthcare systems were included in the analysis. HIV testing and encounter data were abstracted from electronic health records. A missed opportunity for HIV testing was defined as an encounter for an IDU-related condition where an HIV test was not performed and had not been performed in the prior 12 months. RESULTS: Among 109 PWID with HIV diagnosed who had ≥1 healthcare encounter, 75 (68.8%) had ≥1 IDU-related encounters in the 12 months before HIV diagnosis. These 75 PWID had 169 IDU-related encounters of which 86 (50.9%) were missed opportunities for HIV testing and occurred among 46 (42.2%) PWID. Most IDU-related encounters occurred in the emergency department (118/169; 69.8%). Using multivariable generalized estimating equations, HIV testing was more likely in inpatient compared with emergency department encounters (adjusted relative risk [RR], 2.72; 95% confidence interval [CI], 1.70-4.33) and at the healthcare system receiving funding for emergency department HIV testing (adjusted RR, 1.76; 95% CI, 1.10-2.82). CONCLUSIONS: PWID have frequent IDU-related encounters in emergency departments. Enhanced HIV screening of PWID in these settings can facilitate earlier diagnosis and improve outbreak response.
引用
- Furukawa NW, Blau EF, Reau Z, et al. Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018. Clin Infect Dis. 2021. PMID: 32748940. doi:10.1093/cid/ciaa507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。